Hologic To Buy BioLucent For $70 Million, 2 Year Earn Out

Hologic Inc. agreed to acquire BioLucent Inc. for $70 million.

Hologic Inc. agreed to acquire BioLucent Inc., an Aliso Viejo, Calif., medical device company, for $70 million and a two-year earn-out. The purchase price will consist of $5 million in cash and $65 million in cash, shares or a combination of both. The earn-out will be payable in two annual cash installments of up to $15 million. Concurrently with the acquisition, BioLucent will spin off its brachytherapy business into an independent entity. Hologic, Bedford, Mass., is a diagnostic and medical imaging company.

SOURCE: MARKETWATCH.COM

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters